Perinatal asphyxia may influence the level of beta-amyloid (1-42) in cerebrospinal fluid: An experimental study on newborn pigs

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Benterud, Torkil ^a   Pankratov, Leonid ^a   Solberg, Rønnaug ^a   Bolstad, Nils ^a   Skinningsrud, Anders ^b   Baumbusch, Lars ^a   Sandvik, Leiv ^a   Saugstad, Ola Didrik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; LACTIC ACID; NEURON SPECIFIC ENOLASE; PROTEIN S100B; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AMYLOID PRECURSOR PROTEIN; ENOLASE; LACTIC ACID DERIVATIVE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HYPOXIA; MALE; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PIG; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; HIPPOCAMPUS; NEWBORN HYPOXIA;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; ASPHYXIA NEONATORUM; HIPPOCAMPUS; LACTATES; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SWINE;

EID: 84949843770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140966     Document Type: Article

References (26)

1. WHO. World Health Organization. Annual report 2010. 2010.
2. Massaro AN, Chang T, Baumgart S, McCarter R, Nelson KB, Glass P. Biomarkers S100B and Neuron-Specific Enolase Predict Outcome in Hypothermia-Treated Encephalopathic Newborns∗. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2014 Sep; 15(7):615-22. PMID: 24777302. Epub 2014/04/30. eng.
3. Gadad BS, Britton GB, Rao KS. Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. Journal of Alzheimer's disease: JAD. 2011; 24 Suppl 2:223-32. PMID: 21460436. Epub 2011/04/05. eng. doi: 10.3233/JAD-2011-110182
4. Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, et al. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2014 Aug 20. PMID: 25150736. Epub 2014/08/26. Eng.
5. Garcia-Ribas G, Lopez-Sendon Moreno JL, Garcia-Caldentey J. [Biomarkers in Alzheimer's disease]. Revista de neurologia. 2014 Apr 1; 58(7):308-17. PMID: 24677154. Epub 2014/03/29. Biomarcadores en la enfermedad de Alzheimer. spa.
6. de Bont JM, Vanderstichele H, Reddingius RE, Pieters R, van Gool SW. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients. European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society. 2008 Jul; 12(4):334-41. PMID: 17951083. Epub 2007/10/24. eng.
7. Inoue H, Matsushige T, Hasegawa S, Abe A, Iida Y, Inoue T, et al. Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome. Epilepsy Res. 2012 Nov; 102(1-2):8-12. PMID: 22831649. Epub 2012/07/27. eng. doi: 10.1016/j.eplepsyres.2012.07.002
8. Magnoni S, Esparza TJ, Conte V, Carbonara M, Carrabba G, Holtzman DM, et al. Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain: a journal of neurology. 2012 Apr; 135(Pt 4):1268-80. PMID: 22116192. Pubmed Central PMCID: PMC3326246. Epub 2011/11/26. eng.
9. Randall J, Mortberg E, Provuncher GK, Fournier DR, Duffy DC, Rubertsson S, et al. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation. 2013 Mar; 84(3):351-6. PMID: 22885094. Epub 2012/08/14. eng. doi: 10.1016/j.resuscitation.2012.07.027
10. Zetterberg H, Mortberg E, Song L, Chang L, Provuncher GK, Patel PP, et al. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PloS one. 2011; 6 (12):e28263. PMID: 22194817. Pubmed Central PMCID: PMC3237426. Epub 2011/12/24. eng. doi: 10.1371/journal.pone.0028263
11. Mathis G. Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clinical chemistry. 1993 Sep; 39(9):1953-9. PMID: 8375081. Epub 1993/09/01. eng.
12. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in pharmacological sciences. 1991 Oct; 12(10):383-8. PMID: 1763432. Epub 1991/10/01. eng.
13. Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nature reviews Drug discovery. 2011 Sep; 10(9):698-712. PMID: 21852788. Epub 2011/08/20. eng. doi: 10.1038/nrd3505
14. Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, et al. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiology of aging. 2010 Mar; 31(3):357-67. PMID: 18486992. Epub 2008/05/20. eng. doi: 10.1016/j.neurobiolaging.2008.03.027
15. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. The American journal of pathology. 1999 Sep; 155(3):853-62. PMID: 10487842. Pubmed Central PMCID: PMC1866907. Epub 1999/09/17. eng.
16. Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, et al. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Molecular psychiatry. 2009 May; 14(5):469-86. PMID: 18794889. Epub 2008/09/17. eng. doi: 10.1038/mp.2008.96
17. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002 Apr 4; 416(6880):507-11. PMID: 11932737. Epub 2002/04/05. eng.
18. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America. 1998 May 26; 95(11):6448-53. PMID: 9600986. Pubmed Central PMCID: PMC27787. Epub 1998/05/30. eng.
19. Pillot T, Goethals M, Vanloo B, Talussot C, Brasseur R, Vandekerckhove J, et al. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. The Journal of biological chemistry. 1996 Nov 15; 271(46):28757-65. PMID: 8910517. Epub 1996/11/15. eng.
20. Pillot T, Drouet B, Queille S, Labeur C, Vandekerchkhove J, Rosseneu M, et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. Journal of neurochemistry. 1999 Oct; 73(4):1626-34. PMID: 10501209. Epub 1999/09/29. eng.
21. Kecskes Z, Dunster KR, Colditz PB. NSE and S100 after hypoxia in the newborn pig. Pediatric research. 2005 Nov; 58(5):953-7. PMID: 16183811.
22. Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta paediatrica (Oslo, Norway: 1992). 2001 Oct; 90 (10):1171-5. PMID: 11697430. Epub 2001/11/08. eng.
23. van Handel M, de Sonneville L, de Vries LS, Jongmans MJ, Swaab H. Specific memory impairment following neonatal encephalopathy in term-born children. Developmental neuropsychology. 2012; 37 (1):30-50. PMID: 22292830. Epub 2012/02/02. eng. doi: 10.1080/87565641.2011.581320
24. van Handel M, Swaab H, de Vries LS, Jongmans MJ. Behavioral outcome in children with a history of neonatal encephalopathy following perinatal asphyxia. Journal of pediatric psychology. 2010 Apr; 35 (3):286-95. PMID: 19542199. Epub 2009/06/23. eng. doi: 10.1093/jpepsy/jsp049
25. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Multiple cognitive deficits during the transition to Alzheimer's disease. Journal of internal medicine. 2004 Sep; 256(3):195-204. PMID: 15324363. Epub 2004/08/25. eng.
26. Aridas JD, Yawno T, Sutherland AE, Nitsos I, Ditchfield M, Wong FY, et al. Detecting brain injury in neonatal hypoxic ischemic encephalopathy: closing the gap between experimental and clinical research. Experimental neurology. 2014 Nov; 261:281-90. PMID: 25079368. Epub 2014/08/01. eng. doi: 10.1016/j.expneurol.2014.07.009